Skip to content
Subscriber Only

Bayer Loses U.S. High Court Case on Baycol Class-Action Suit

The U.S. Supreme Court cleared the way for two West Virginians to seek class-action status in a suit against a Bayer AG unit over its withdrawn cholesterol drug Baycol.

The justices today unanimously overturned a decision that said the pair was bound by a ruling rejecting a West Virginia class-action bid in an earlier Baycol suit.